Dosimetric comparison of incidental axillary irradiation between three-dimensional conformal and volumetric modulated arc techniques for breast cancer.

axillary irradiation breast cancer dosimetry incidental irradiation lymphedema radiotherapy

Journal

Molecular and clinical oncology
ISSN: 2049-9450
Titre abrégé: Mol Clin Oncol
Pays: England
ID NLM: 101613422

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 07 03 2019
accepted: 04 02 2020
entrez: 28 4 2020
pubmed: 28 4 2020
medline: 28 4 2020
Statut: ppublish

Résumé

Radiotherapy techniques for breast cancer have evolved with efforts to reduce treatment-related side effects. In the present study, we conducted dosimetric analysis of incidental axillary irradiation between volumetric modulated arc therapy (VMAT) and three-dimensional conformal radiotherapy (3D-CRT). A total of 20 patients with early stage left breast cancer who underwent breast-conserving surgery followed by postoperative radiotherapy were analyzed. For VMAT plans, dose-volume constraints were not imposed on the axilla, as with 3D-CRT. We compared the dosimetric parameters of the planning target volumes, organs at risk and axillary level I-III of the two plans. VMAT showed better target coverage and a normal organ-sparing effect compared with 3D-CRT. The incidental axillary irradiation of VMAT was lower; the mean dose and the V40

Identifiants

pubmed: 32337037
doi: 10.3892/mco.2020.2022
pii: MCO-0-0-2022
pmc: PMC7179387
doi:

Types de publication

Journal Article

Langues

eng

Pagination

551-556

Informations de copyright

Copyright © 2020, Spandidos Publications.

Références

Med Dosim. 2016 Autumn;41(3):253-7
pubmed: 27545009
Oncotarget. 2015 Jul 20;6(20):18183-91
pubmed: 26082440
Curr Probl Surg. 2016 Dec;53(12):559-595
pubmed: 28160790
N Engl J Med. 2018 Nov 15;379(20):1937-1944
pubmed: 30428297
J Appl Clin Med Phys. 2010 Sep 28;12(1):3320
pubmed: 21330979
Radiat Oncol J. 2018 Mar;36(1):71-78
pubmed: 29621872
Asian Pac J Cancer Prev. 2014;15(11):4727-32
pubmed: 24969911
Radiat Oncol. 2011 Mar 21;6:26
pubmed: 21418616
J Radiat Res. 2015 Nov;56(6):883-8
pubmed: 26454068
Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):358-64
pubmed: 15667953
Oncotarget. 2017 Jan 10;8(2):3059-3063
pubmed: 27997358
Lancet Oncol. 2005 Aug;6(8):557-65
pubmed: 16054566
JAMA. 2017 Sep 12;318(10):918-926
pubmed: 28898379
Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):565-71
pubmed: 24411624
Lymphat Res Biol. 2018 Apr;16(2):134-139
pubmed: 29437542
Breast Care (Basel). 2011 Oct;6(5):369-374
pubmed: 22619647
Br J Radiol. 2013 Dec;86(1032):20130515
pubmed: 24167182
Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):327-33
pubmed: 10802356
Medicine (Baltimore). 2016 Jun;95(26):e4036
pubmed: 27368030
Lancet Oncol. 2018 Oct;19(10):1385-1393
pubmed: 30196031
Strahlenther Onkol. 2013 May;189(5):367-71
pubmed: 23549780
Lancet Oncol. 2014 Nov;15(12):1303-10
pubmed: 25439688
Oncotarget. 2016 Apr 19;7(16):22960-9
pubmed: 27027239
In Vivo. 2018 Nov-Dec;32(6):1301-1307
pubmed: 30348682
Trials. 2018 Dec 4;19(1):667
pubmed: 30514362
Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):71-78
pubmed: 30102206
Breast Cancer. 2017 Jan;24(1):52-62
pubmed: 27025498
N Engl J Med. 1999 Feb 4;340(5):383-5
pubmed: 9929532
Oncol Rep. 2014 May;31(5):2195-205
pubmed: 24604635
Radiat Oncol. 2010 Jun 19;5:56
pubmed: 20565899
Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):83-8
pubmed: 12694826
J Reconstr Microsurg. 2016 Jul;32(6):484-90
pubmed: 26919383
Expert Opin Drug Saf. 2017 Sep;16(9):1021-1038
pubmed: 28697311
Br J Radiol. 2011 Nov;84(1007):967-96
pubmed: 22011829
Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1559-68
pubmed: 11121662
Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):257-65
pubmed: 26383674
Tumori. 2016 Aug 3;102(4):335-6
pubmed: 27339088
Breast. 2016 Aug;28:29-36
pubmed: 27183497
Breast Cancer Res Treat. 2015 Oct;153(3):549-56
pubmed: 26358709
Breast. 2013 Dec;22(6):1125-9
pubmed: 24012148
N Engl J Med. 1989 Mar 30;320(13):822-8
pubmed: 2927449
Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1238-50
pubmed: 17512134
J Thorac Dis. 2019 Jun;11(6):2229-2239
pubmed: 31372260

Auteurs

In Young Jo (IY)

Department of Radiation Oncology, Soonchunhyang University Hospital, Cheonan, Chungnam 31151, Republic of Korea.

Eun Seog Kim (ES)

Department of Radiation Oncology, Soonchunhyang University Hospital, Cheonan, Chungnam 31151, Republic of Korea.
Department of Radiation Oncology, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Cheonan, Chungnam 31151, Republic of Korea.

Woo Chul Kim (WC)

Department of Radiation Oncology, Soonchunhyang University Hospital, Cheonan, Chungnam 31151, Republic of Korea.

Chul Kee Min (CK)

Department of Radiation Oncology, Soonchunhyang University Hospital, Cheonan, Chungnam 31151, Republic of Korea.

Seung-Gu Yeo (SG)

Department of Radiation Oncology, Soonchunhyang University Hospital, Cheonan, Chungnam 31151, Republic of Korea.
Department of Radiation Oncology, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Cheonan, Chungnam 31151, Republic of Korea.

Classifications MeSH